Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience-Reference-Cited by-同舟云学术

Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience

Published:2021-03-12 Issue:4 Volume:304 Page:975-984
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Pauly Nina^ORCID,Baert Thaïs,Schmutzler Rita,du Bois Andreas,Schneider Stephanie,Rhiem Kerstin,Schömig-Markiefka Birgid,Siemanowski Janna,Heikaus Sebastian,Traut Alexander,Heitz Florian,Prader Sonia,Ehmann Sarah,Harter Philipp,Ataseven Beyhan

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00404-021-06006-w.pdf

Reference44 articles.

1. Koch-Institut R (2017) Krebs in Deutschland für 2013/2014. Robert Koch-Institut. https://doi.org/10.17886/rkipubl-2017-007

2. Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, Group E-E-EECCW (2016) ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26(1):2–30. https://doi.org/10.1097/IGC.0000000000000609

3. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66(15):7810–7817. https://doi.org/10.1158/0008-5472.CAN-06-1114

4. Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB (2014) Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol 32(2):90–100. https://doi.org/10.1200/JCO.2013.51.2129

5. Berends MJ, Wu Y, Sijmons RH, van der Sluis T, Ek WB, Ligtenberg MJ, Arts NJ, ten Hoor KA, Kleibeuker JH, de Vries EG, Mourits MJ, Hollema H, Buys CH, Hofstra RM, van der Zee AG (2003) Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 21(23):4364–4370. https://doi.org/10.1200/JCO.2003.04.094

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on Institutional Implementation of Screening for Mismatch Repair Deficiency and Lynch Syndrome in Endometrial Cancer Patients;Cancers;2024-02-04

2. Prevention of endometrial cancer in Lynch syndrome;Die Gynäkologie;2023-11-09

3. Immune checkpoint inhibitors: here to stay;Translational Cancer Research;2023-10

4. Research Progress of DNA Methylation in Endometrial Cancer;Biomolecules;2022-07-04